Boryung Pharm (003850) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.060x

Based on the latest financial reports, Boryung Pharm (003850) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩48.95 Billion ≈ $33.18 Million USD) by net assets (₩818.35 Billion ≈ $554.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Boryung Pharm - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Boryung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Boryung Pharm carry for a breakdown of total debt and financial obligations.

Boryung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boryung Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hovnanian Enterprises Inc NYSE:HOV	0.168x
VersaBank TO:VBNK	-0.112x
Worldline SA PA:WLN	0.037x
Turvo International Co Ltd TW:2233	0.030x
Ningbo Lehui International Engineering Equipment Co Ltd Class A SHG:603076	0.088x
Shenzhen Silver Basis Technology Co Ltd SHE:002786	0.239x
GuangDong GenSho Logistics Co SHG:603813	-0.030x
Zhejiang Extek Technology Co. Ltd. A SHE:301399	N/A

Annual Cash Flow Conversion Efficiency for Boryung Pharm (2009–2024)

The table below shows the annual cash flow conversion efficiency of Boryung Pharm from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Boryung Pharm stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩784.50 Billion ≈ $531.65 Million	₩80.56 Billion ≈ $54.59 Million	0.103x	+33.57%
2023-12-31	₩549.25 Billion ≈ $372.22 Million	₩42.22 Billion ≈ $28.61 Million	0.077x	+42.73%
2022-12-31	₩516.42 Billion ≈ $349.97 Million	₩27.81 Billion ≈ $18.85 Million	0.054x	-57.54%
2021-12-31	₩474.31 Billion ≈ $321.44 Million	₩60.17 Billion ≈ $40.77 Million	0.127x	-3.52%
2020-12-31	₩340.29 Billion ≈ $230.61 Million	₩44.74 Billion ≈ $30.32 Million	0.131x	-20.84%
2019-12-31	₩282.95 Billion ≈ $191.75 Million	₩47.00 Billion ≈ $31.85 Million	0.166x	+9.32%
2018-12-31	₩256.10 Billion ≈ $173.56 Million	₩38.91 Billion ≈ $26.37 Million	0.152x	+254.12%
2017-12-31	₩249.65 Billion ≈ $169.19 Million	₩-24.61 Billion ≈ $-16.68 Million	-0.099x	-305.69%
2016-12-31	₩195.35 Billion ≈ $132.39 Million	₩9.36 Billion ≈ $6.35 Million	0.048x	-61.98%
2012-12-31	₩145.79 Billion ≈ $98.80 Million	₩18.38 Billion ≈ $12.46 Million	0.126x	+89.34%
2011-12-31	₩137.97 Billion ≈ $93.50 Million	₩9.19 Billion ≈ $6.23 Million	0.067x	-62.35%
2010-12-31	₩136.41 Billion ≈ $92.44 Million	₩24.12 Billion ≈ $16.35 Million	0.177x	+510.22%
2009-12-31	₩124.01 Billion ≈ $84.04 Million	₩3.59 Billion ≈ $2.44 Million	0.029x	--

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$569.08 Million

₩839.74 Billion KRW

Market Cap Rank

#11864 Global

#371 in Korea

Share Price

₩9940.00

Change (1 day)

-1.39%

52-Week Range

₩8170.00 - ₩10680.00

All Time High

₩21257.60